Neurocrine Biosciences (NASDAQ:NBIX) Earnings Information
Neurocrine Biosciences last released its quarterly earnings results on February 3rd, 2021. The reported $3.58 EPS for the quarter, topping analysts' consensus estimates of $0.59 by $2.99. Neurocrine Biosciences has generated $0.39 earnings per share over the last year and currently has a price-to-earnings ratio of 118.9. Neurocrine Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 5th, 2021 based off prior year's report dates.
Neurocrine Biosciences Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
Neurocrine Biosciences (NASDAQ:NBIX) Earnings Estimates
2021 EPS Consensus Estimate: $2.95
2022 EPS Consensus Estimate: $5.28
Neurocrine Biosciences (NASDAQ NBIX) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)